Steady, relentless progress towards effective, safe screening for early detection of cancer of the ovary.

Date: 
22 Aug 2017
Source: 
NCBI
Audience: 
Patients and public
Type of resource: 
Research

The quest for early detection of ovarian cancer (OC), in the hope of reducing mortality, began as soon as the correlation between stage and survival were documented >50 years ago. Research commenced in earnest in the 1980s when the CA 125 test became available1 and ultrasound technology was able to image the ovary2 . The challenges were quickly recognised. Alongside acceptability, compliance and cost two issues needed addressing before large randomised trials with mortality as an end point could be justified. This article is protected by copyright. All rights reserved.

 

Please click here to read the research abstract